Exact Mass: 378.0409364
Exact Mass Matches: 378.0409364
Found 144 metabolites which its exact mass value is equals to given mass value 378.0409364,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
7-Methylguanosine 5'-phosphate
7-methylguanosine 5-phosphate is part of the RNA degradation pathway. It is a substrate for: m7GpppX diphosphatase, and m7GpppX diphosphatase.
Carbenicillin
Carbenicillin is only found in individuals that have used or taken this drug. It is a broad-spectrum semisynthetic penicillin derivative used parenterally. It is susceptible to gastric juice and penicillinase and may damage platelet function. [PubChem]Free carbenicillin is the predominant pharmacologically active fraction of the salt. Carbenicillin exerts its antibacterial activity by interference with final cell wall synthesis of susceptible bacteria. Penicillins acylate the penicillin-sensitive transpeptidase C-terminal domain by opening the lactam ring. This inactivation of the enzyme prevents the formation of a cross-link of two linear peptidoglycan strands, inhibiting the third and last stage of bacterial cell wall synthesis. Cell lysis is then mediated by bacterial cell wall autolytic enzymes such as autolysins; it is possible that carbenicillin interferes with an autolysin inhibitor. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01C - Beta-lactam antibacterials, penicillins > J01CA - Penicillins with extended spectrum D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic
Chlorflavonin
A dihydroxyflavone that is flavone substituted by a chloro group at position 3, hydroxy groups at positions 5 and 2 and methoxy groups at positions 3, 7 band 8 respectively.
6-Methylthiopurine 5'-monophosphate ribonucleotide
C11H15N4O7PS (378.03990500000003)
6-Methylthiopurine 5-monophosphate ribonucleotide, also known as methylthioinosine-5-monophosphate or meTIMP, is a metabolite of mercaptopurine. Mercaptopurine (also called 6-mercaptopurine, 6-MP, or its brand name Purinethol) is an immunosuppressive drug. Mercaptopurine is in the thiopurine and antimetabolite family of medications (Wikipedia). MeTIMP produced from 6-thioinosine monophosphate (6-TIMP) by thiopurine methyltransferase (TPMT) is an active metabolite that can inhibit de novo purine biosynthesis. High concentration of meTIMP has been related to hepatotoxicity and myelotoxicity (PMID: 21311411).
3,4,5-trihydroxy-6-({7-oxo-7H-furo[3,2-g]chromen-4-yl}oxy)oxane-2-carboxylic acid
C17H14O10 (378.05869440000004)
3,4,5-trihydroxy-6-({7-oxo-7h-furo[3,2-g]chromen-4-yl}oxy)oxane-2-carboxylic acid is a predicted metabolite generated by BioTransformer¹ that is produced by the metabolism of 4-hydroxy-7h-furo[3,2-g]chromen-7-one. It is generated by UDP-glucuronosyltransferase 1-1 (P22309) enzyme via an aromatic-OH-glucuronidation reaction. This aromatic-OH-glucuronidation occurs in humans.
Enterolactone 3'-sulfate
C18H18O7S (378.07731980000005)
Enterolactone 3'-sulfate
C18H18O7S (378.07731980000005)
6-Methylthiopurine ribonucleoside
C11H15N4O7PS (378.03990500000003)
Edta oxalate
Pentafluorobenzyl ether
1-[[Difluoro-(2,3,4-trifluorophenyl)methoxy]-difluoromethyl]-2,3,4-trifluorobenzene
Casoxin D
Isolated from the proteolytic digest of human milk casein
6-Bromo-1-ethoxy-1,8-dihydroaplysinopsin
C16H19BrN4O2 (378.06912939999995)
(2R,5aS,7S,9aS)-7-Bromo-2-(bromomethyl)-2,5,5a,6,7,8,9,9a-octahydro-3,6,6,9a-tetramethyl-1-benzoxepin
C15H24Br2O (378.01937739999994)
(8R*)-8-Bromo-10-epi-beta-Snyderol
C15H24Br2O (378.01937739999994)
2-Bromo-4-(4-bromo-3,3-dimethylcyclohexyl)-1-methyl-7-oxabicyclo[2.2.1]heptane
C15H24Br2O (378.01937739999994)
Anastatin A
anastatin B
Methyl 3-[2-(dicyanomethylidene)hydrazino]-4-[(2-furylmethyl)sulfonyl]thiophene-2-carboxylate
3-(2-chloro-6-fluorophenyl)-N-(5-cyclopropyl-1,3,4-thiadiazol-2-yl)-5-methyl-1,2-oxazole-4-carboxamide
2-(4-Chlorobenzoyl)-3-{[1-(4-chlorophenyl)-1-methyl-1-oxo-λ6-sulfanylidene]amino}acrylonitrile
62FTA
Disclaimer: While authors make an effort to ensure that the content of this record is accurate, the authors make no representations or warranties in relation to the accuracy or completeness of the record. This record do not reflect any viewpoints of the affiliation and organization to which the authors belong.
jusmicranthin methyl ester|jusmicranthin methyl ether
(ent-6alpha,8alpha,10beta,12betaH)-17-Chloro-15,16-epoxy-8-hydroxy-19-nor-4,13(16),14-clerodatriene-18,6:20,12-diolide
14-hydroxy-8beta-methacryloyloxy-3-chlorodehydroleucodin
(2S*,6R*,8R*,9R*)-2,8-dibromo-9-hydroxy-beta-chamigrene
C15H24Br2O (378.01937739999994)
5-Chlor-dermorubin|6,8-Di-Me ether,5-chloro-1,4,6,8-Tetrahydroxy-3-methyl-2-anthraquinonecarboxylic acid
5-(3,4-Dimethoxyphenyl)naphtho[2,3-d]-1,3-dioxole-6,7-dicarboxylic anhydride
7-methylguanosine 5'-phosphate
N-(2,5-difluorophenyl)-5-[4-(trifluoromethyl)phenyl]pyridine-3-carboxamide
N-(2,5-difluorophenyl)-5-[3-(trifluoromethyl)phenyl]pyridine-3-carboxamide
Thiazolidine, 3-[(4-methyl-3-nitrophenyl)sulfonyl]-2-(4-methylphenyl)- (9CI)
Polyethylene glycol, disulfobutyl ether, disodium salt
3-(4-Bromo[1,1-biphenyl]-4-yl)-1,2,3,4-tetrahydro-1-naphthalenol
Copper(I) hexafluoro-2,4-pentanedionate-1,5-cyclooctadiene complex
(2R)-7β-Bromo-2-(bromomethyl)-2,5,5aα,6,7,8,9,9a-octahydro-3,6,6,9aβ-tetramethyl-1-benzoxepin
C15H24Br2O (378.01937739999994)
Methyl 2-[5-[2-(2,4-Dichlorophenoxy)phenyl]-2H-tetrazol-2-yl]acetate
C16H12Cl2N4O3 (378.02864220000004)
(4-methoxyphenyl) 4-phenyl-5-(trifluoromethyl)thiophene-2-carboxylate
1-Piperazineethanol, 4-[(5-bromo-2-methoxyphenyl)sulfonyl]
Vortioxetine hydrobromide
D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017367 - Selective Serotonin Reuptake Inhibitors D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent D049990 - Membrane Transport Modulators Vortioxetine hydrobromide is a multimodal serotonergic agent, inhibits 5-HT1A, 5-HT1B, 5-HT3A, 5-HT7 receptor and SERT with Ki values of 15 nM, 33 nM, 3.7 nM, 19 nM and 1.6 nM, respectively.
3,5-bis-(Chloromethyl)octamethyltetrasiloxane
C10H28Cl2O3Si4 (378.04925180000004)
1-(2,6-Dichlorophenyl)-2-indolinone
C18H16Cl2N2O3 (378.05379259999995)
5-[(3-ethylbenzothiazol-2(3H)-ylidene)ethylidene]-4-oxo-2-thioxothiazolidin-3-acetic acid
C16H14N2O3S3 (378.01665340000005)
(3,5-bis(trifluoromethyl)phenyl)(3,4-dimethoxyphenyl)methanone
4,6-dimethylpyrimidin-2-ol--1,2,3,4-tetrahydro-2-methyl-1,4-dioxonaphthalene-2-sulphonic acid (1:1)
5-ethyl-N-[2-(2-phenyl-4-thiazolyl)ethyl]-2-thiophenesulfonamide
C17H18N2O2S3 (378.05303680000003)
2-[[3-(4-Methoxyphenyl)-4-oxo-6,7-dihydrothieno[3,2-d]pyrimidin-2-yl]thio]acetic acid ethyl ester
(5-Bromo-2-furanyl)-[2-[(3-methylphenyl)methylthio]-4,5-dihydroimidazol-1-yl]methanone
2-Bromo-2-(((4-methylphenyl)sulfonyl)methyl)-1-indanone
N-({3-Hydroxy-2-methyl-5-[(phosphonooxy)methyl]pyridin-4-YL}methyl)-D-glutamic acid
3,3,4,4,5,5,6,6,7,7,8,8,8-Tridecafluorooctanoic acid
[(2R,3S,4R,5R)-3,4-dihydroxy-5-(2,6,8-trioxo-3,7-dihydropurin-9-yl)oxolan-2-yl]methyl phosphate
1-(4-Acetylphenyl)-3-[(4-nitrophenyl)sulfonylamino]urea
C15H14N4O6S (378.06340240000003)
[4-[(2,4-Dichlorophenoxy)methyl]phenyl]-(4-methyl-1-piperazinyl)methanone
4-(3-Bromophenyl)-7-methyl-2-(4-methylphenyl)pyrazolo[3,4-d]pyridazine
2-(1,3-benzothiazol-2-ylthio)-N-(4-methylphenyl)sulfonylacetamide
C16H14N2O3S3 (378.01665340000005)
N-[[[(2-chlorophenyl)-oxomethyl]hydrazo]-sulfanylidenemethyl]-2-nitrobenzamide
C15H11ClN4O4S (378.01895160000004)
N-[5-[methyl-(3-methylphenyl)sulfamoyl]-1,3,4-thiadiazol-2-yl]-2-furancarboxamide
(E)-3-[1-(benzenesulfonyl)pyrrol-2-yl]-2-tert-butylsulfonylprop-2-enenitrile
6-bromo-N-(2-methylphenyl)-2-pyridin-4-yl-3-imidazo[1,2-a]pyridinamine
N-cyclopropyl-4-(2,3-dihydroindol-1-ylsulfonyl)benzenesulfonamide
6-[2-(5-Chloro-2-methoxyanilino)-2-oxoethyl]-5-thieno[2,3-b]pyrrolecarboxylic acid methyl ester
C17H15ClN2O4S (378.04410200000007)
N-(4-bromo-2-fluorophenyl)-1-methylsulfonyl-4-piperidinecarboxamide
5-fluoro-3-[(4-methoxyphenyl)sulfonylamino]-1H-indole-2-carboxylic acid methyl ester
N-[5-[ethyl(phenyl)sulfamoyl]-1,3,4-thiadiazol-2-yl]-2-furancarboxamide
N-[[2-methyl-5-(2-oxazolo[4,5-b]pyridinyl)anilino]-sulfanylidenemethyl]-2-furancarboxamide
N-(3,5-dimethoxyphenyl)-6-methyl-3-oxo-4H-1,4-benzoxazine-7-sulfonamide
2-(Benzenesulfonamido)acetic acid [2-(4-nitrophenyl)-2-oxoethyl] ester
N-[(E)-[5-chloro-1-(3-chlorophenyl)-3-methylpyrazol-4-yl]methylideneamino]thiophene-2-carboxamide
4-[(E)-[4-(furan-2-yl)-2-pyridin-3-ylimino-1,3-thiazol-3-yl]iminomethyl]benzene-1,3-diol
5,7-Dimethyl-2-methylamino-4-(3-pyridylmethyl)-1,3-benzothiazol-6-yl sulfate
5-bromo-N-(6-butyl-1,3-benzothiazol-2-yl)-2-furancarboxamide
3-[2-(2-Naphthalenylsulfonyl)-1-oxoethyl]-1-benzopyran-2-one
C21H14O5S (378.05619140000005)
[3-[(E)-(1,3-benzodioxole-5-carbonylhydrazinylidene)methyl]phenyl] furan-2-carboxylate
(3R)-3-(2-chloro-1,3-thiazol-5-yl)-5-hydroxy-8-methyl-6-phenyl-2,3-dihydro-[1,3]thiazolo[3,2-a]pyrimidin-4-ium-7-one
Carbenicillin
J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01C - Beta-lactam antibacterials, penicillins > J01CA - Penicillins with extended spectrum D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic A penicillin antibiotic having a 6beta-2-carboxy-2-phenylacetamido side-chain.
tetracenomycin D3(2-)
A hydroxy monocarboxylic acid anion obtained by deprotonation of the carboxy and 8-hydroxy groups of tetracenomycin D3. It is the major microspecies at pH 7.3 (according to Marvin v 6.2.0.).
6-Methylthioinosine-5-monophosphate
C11H15N4O7PS (378.03990500000003)
3,4,5-trihydroxy-6-({7-oxo-7H-furo[3,2-g]chromen-4-yl}oxy)oxane-2-carboxylic acid
C17H14O10 (378.05869440000004)
5,7-dimethyl-2-methylamino-4-(3-pyridylmethyl)-1,3-benzothiazol-6-yl sulfate(1-)
An aryl sulfate oxoanion that is the conjugate base of 5,7-dimethyl-2-methylamino-4-(3-pyridylmethyl)-1,3-benzothiazol-6-yl hydrogen sulfate, obtained by deprotonation of the sulfo group; major species at pH 7.3.
2-{3,5-dibromo-4-[3-(dimethylamino)propoxy]phenyl}ethanamine
C13H20Br2N2O (377.99422699999997)
5-[(1r,3r)-3,5-dibromo-2,2-dimethyl-6-methylidenecyclohexyl]-3-methylpent-1-en-3-ol
C15H24Br2O (378.01937739999994)
4',6,7,8-tetrahydroxy-1-methyl-1'h-spiro[naphtho[2,3-c]furan-4,2'-quinazolin]-9-one
(3s,4'r,5s,6's,8'r)-6'-(chloromethyl)-5-(furan-3-yl)-6'-hydroxy-3'-oxaspiro[oxolane-3,7'-tricyclo[6.3.1.0⁴,¹²]dodecan]-1'(12')-ene-2,2'-dione
10-(7-methoxy-2h-1,3-benzodioxol-5-yl)-4,6,13-trioxatetracyclo[7.7.0.0³,⁷.0¹¹,¹⁵]hexadeca-1,3(7),8,10,15-pentaen-12-one
(3s)-5-[(1s,3s,5s)-3,5-dibromo-2,2-dimethyl-6-methylidenecyclohexyl]-3-methylpent-1-en-3-ol
C15H24Br2O (378.01937739999994)
(3ar,4r,9ar,9br)-8-chloro-6-(hydroxymethyl)-9-methyl-3-methylidene-2,7-dioxo-3ah,4h,5h,9ah,9bh-azuleno[4,5-b]furan-4-yl 2-methylprop-2-enoate
(2r,3r,6r,8s)-2,8-dibromo-3,7,7-trimethyl-11-methylidenespiro[5.5]undecan-3-ol
C15H24Br2O (378.01937739999994)
(3r)-5-[(1r,3r,5r)-3,5-dibromo-2,2-dimethyl-6-methylidenecyclohexyl]-3-methylpent-1-en-3-ol
C15H24Br2O (378.01937739999994)